Advances in Infectious Diseases & Therapy is an international open access, peer-reviewed journal that considers articles on all aspects of the prevention,
Advances in Infectious Diseases & Therapy (ISSN 2769-2787) is an international open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of infectious diseases in humans. The Journal also considers the clinical and laboratory-based research, novel developments in treatment and control of diseases. Considering the importance and wider research context the journal integrates research from various areas of biology and its related health applications.
Advances in Infectious Diseases & Therapy will feature original research, review papers, clinical studies, editorials, expert opinion and perspective papers, commentaries, and book reviews. Please, follow the Instructions for Authors for detailed description regarding the formats and submission procedures.
Background: The COVID-19 pandemic exposed critical weaknesses in multisectoral coordination across West Africa, a region highly vulnerable to zoonotic disease e...
People living with HIV (ILWH) are believed to be vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections due to their lowered immu...
The prevalence of Urinary Tract Infection (UTI) varies by age, sex, race, pregnancy status, and pathology, with an increasing burden among older adults and thos...
Objectives: This study investigates the residual risk of mother-to-child transmission (MTCT) of HIV among women living with HIV who are on sustained antiretrovi...
Introduction: As 2023, Africa accounted for nearly two-thirds of the global population living with HIV. Research is essential in achieving the goal of eliminati...
Dengue is currently the most common mosquito-borne disease globally. In Oman, all reported dengue cases were travel-rela...
Purpose: Remdesivir has become a part of the treatment standard for patients hospitalized with COVID-19 since its initia...
Background: Azithromycin (AZT) has been proposed as a treatment for COVID-19 on the basis of its immunomodulatory action...